Eyestem

Biotech company Eyestem’s valuation surges 70% in Series B round

Clinical-stage biotech company Eyestem Research recently secured $10 million in a Series B round led by Prabhavati Agro Green Energies with the participation of Jacesa Investments, BNS Capital, Alkem Labs, among others.